查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1863187

全球氧氣療法治療設備市場：洞察、競爭格局及至2032年預測

Oxygen Therapy Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

氧氣療法設備市場摘要

  • 全球氧氣療法設備市場預計將從 2024 年的 32.9577 億美元穩步成長到 2032 年的 58.6674 億美元。
  • 全球氧氣療法設備市場預計在 2025 年至 2032 年的預測期內將以 7.52% 的複合年成長率成長。
  • 受呼吸系統疾病發病率上升、加護治療應用範圍擴大以及技術快速進步的推動，全球氧氣療法設備市場正經歷強勁成長。慢性阻塞性肺病（COPD）、氣喘和其他慢性肺部疾病發生率的不斷攀升，推動了醫院和居家醫療機構對持續氧氣治療的需求。在加護病房，氧氣設備對於治療嚴重呼吸系統或心臟併發症的患者至關重要。同時，人工智慧整合式製氧機、即時監測和攜帶式設計等創新技術，正在提高治療的精準度和患者的便利性。這些因素共同推動了氧氣療法設備的廣泛應用，並鞏固了市場的成長勢頭。
  • 氧氣療法設備市場的主要企業包括 Koninklijke Philips NV、Invacare Corporation、Inogen, Inc.、Dragerwerk AG & Co. KgaA、ICU Medical, Inc.、CAIRE Inc.、Fisher & Paykel Healthcare Limited、Armstrong Medical、Vyaire MedicalBMC, Inc.、Hamilton Medical、深圳. Industries, Inc.、DeVilbiss Healthcare LLC、GCE Group、Oxygen Solutions Inc. 和 Besco Medical Limited。
  • 北美憑藉其完善的醫療保健基礎設施、高發的慢性呼吸系統疾病和其他慢性疾病以及老齡化人口，在全球氧氣療法設備市場佔最大佔有率。該地區對攜帶式和固定式氧氣濃縮機、人工智慧整合監測系統以及智慧氧氣輸送設備等醫療技術的先進應用，進一步鞏固了其市場主導地位。家庭氧氣療法需求的不斷成長，加上持續的技術創新和患者支援計劃，正在加速氧氣治療設備的普及，並確保其持續成長。這些因素共同促成了北美在全球氧氣療法設備市場中主導且極具影響力的地位。
  • 在按產品類型分類的氧氣療法設備市場區隔中，預計到 2024 年，系統導管類產品將佔最大的市場佔有率。

推動氧氣療法設備市場成長的因素

  • 呼吸系統疾病病例激增推動氧氣療法設備市場快速成長：慢性慢性阻塞性肺病肺病（COPD）、氣喘、睡眠呼吸中止症和肺炎等慢性及急性呼吸系統疾病的日益普遍，是氧氣療法設備市場的主要促進因素之一。世界衛生組織（WHO）指出，COPD仍然是全球導致發病率和死亡率的主要原因之一，尤其是在人口老化和空氣污染嚴重的地區。呼吸衰竭和低氧血症患者數量的不斷成長，顯著推動了對氧氣濃縮機、氧氣瓶和攜帶式氧氣設備的需求。此外，吸煙、職業性接觸有毒氣體以及都市區空氣污染等生活方式因素也加劇了呼吸系統併發症的發生，促使臨床和居家照護機構擴大採用氧氣療法。隨著醫療保健系統將長期呼吸支持解決方案列為優先事項，疾病負擔的不斷加重將繼續推動市場發展。
  • 這些設備在加護治療中的關鍵應用：氧氣療法設備在加護治療環境中發揮至關重要的作用，維持最佳氧氣濃度對於患者的生存和康復至關重要。醫院和加護病房(ICU) 越來越依賴先進的氧氣輸送系統來管理患有嚴重呼吸窘迫、術後併發症和心臟疾病的患者。呼吸衰竭、創傷和敗血症急診入院人數的增加進一步推動了對高性能固定式製氧機、人工呼吸器和氧氣輸送介面的需求。此外，監測技術和整合式氧氣流量系統的進步使醫護人員能夠提供精確的氧濃度，有助於改善病患的治療效果。隨著加護治療基礎設施的不斷完善和對先進呼吸支援的日益重視，氧氣療法設備在急性護理環境中的應用持續推動全球市場的發展。
  • 產品研發的快速創新：持續的技術進步正在改變氧氣療法設備的格局，提升便攜性、效率和病患舒適度。現代氧氣濃縮機採用緊湊型設計、長電池續航時間、自動流量調節和智慧連接功能，可實現遠端監控和控制。人工智慧 (AI) 和物聯網 (IoT) 技術的整合，能夠即時追蹤氧氣使用情況和患者生命徵象，從而最佳化治療依從性和臨床決策。此外，製造商還引入降噪系統、輕質材料和方便用戶使用型介面，以改善患者體驗，尤其是在居家醫療環境中。這些創新正在擴大氧氣療法的覆蓋範圍，使其不再局限於醫院，並幫助患者獨立管理慢性呼吸系統疾病。因此，產品的快速發展正在推動氧氣療法設備市場的廣泛應用，並保持其長期成長動能。

「氧氣療法設備市場報告」全面概述了全球氧氣療法設備市場，重點分析了關鍵趨勢、成長要素、挑戰和機會。報告按產品類型、便攜性、應用、最終用戶和地區進行了詳細的市場區隔。報告深入分析了北美、歐洲和亞太地區等主要市場的競爭格局、法規環境和市場動態，並詳細介紹了主要行業參與者和最新產品創新，為企業提供關鍵數據，以識別市場潛力、制定戰略規劃，並在快速成長的氧氣療法設備市場中把握新機會。

氧氣療法設備是為患有呼吸系統疾病或低氧血症的患者提供補充氧氣的​​醫療設備。這些設備包括氧氣濃縮機、氧氣瓶、液態氧系統以及各種輸送介面，例如面罩、氧氣鼻管和人工呼吸器。它們廣泛應用於醫院、診所和居家醫療機構，幫助慢性阻塞性肺病（COPD）、氣喘和其他肺部疾病患者維持足夠的氧飽和度並改善整體呼吸功能。

氧氣療法設備市場的成長主要受呼吸系統疾病發病率上升、加護治療室（ICU）中氧療設備使用量增加以及產品研發技術的快速創新所驅動。慢性呼吸系統疾病（如慢性阻塞性肺病、氣喘和睡眠呼吸中止症）的日益普遍，加上空氣污染和吸菸等環境因素，顯著增加了醫院和居家醫療機構對氧氣療法解決方案的需求。在加護治療室中，氧氣療法設備在穩定呼吸窘迫、心臟併發症和術後患者方面發揮關鍵作用，促進了其在ICU和急診的應用。同時，設備技術的快速發展，包括小型化、節能型和人工智慧整合型製氧機的研發，提高了治療的準確性、患者的舒適度和移動性。即時氧氣監測、自動流量調節和無線連接等功能使氧氣療法更加便捷易用，尤其適合長期居家使用。這些因素，加上技術進步以及臨床和家庭對可靠呼吸支持解決方案日益成長的需求，共同推動了市場擴張。

由於臨床、人口、環境和技術因素的共同作用，全球氧氣療法設備市場正在經歷強勁且持續的成長，而氣喘和慢性阻塞性肺病(COPD) 等慢性呼吸系統疾病的日益普遍是主要的成長要素。

根據DelveInsight的分析（2025年），全球有超過2.5億人患有氣喘，使其成為各年齡層中最常見的慢性疾病之一。同時，預計到2050年，慢性阻塞性肺病（COPD）患者人數將達到6億人。空氣污染加劇、菸草使用普遍、氣候變遷、職業危害和快速都市化等環境因素進一步加劇了呼吸系統疾病的快速成長。此外，老年人口的不斷成長，使得老年人患慢性病和反覆住院的風險更高，從而增加了醫院、加護病房、門診機構和居家醫療機構對氧氣療法設備的需求。

在加護治療環境中，對持續氧療的需求不斷成長，尤其是那些患有嚴重呼吸窘迫、心臟併發症和術後併發症的患者，需要可靠的氧氣供應，這進一步推動了市場對氧氣支持的需求。同時，科技的快速發展正在改變這個產業。攜帶式和固定式氧氣濃縮機、人工智慧整合監測系統、智慧輸氧設備以及方便用戶使用型介面等創新技術，提高了治療的精準度，改善了患者的舒適度，並促進了治療依從性。此外，攜帶式和連網設備在居家照護解決方案中的日益普及，也為長期呼吸系統疾病患者提供了更多便利。

支持性的法規結構、對早期診斷和適當介入的日益重視，以及不斷加強的病患教育，正進一步加速氧氣療法設備的普及應用。這些因素共同凸顯了氧氣療法解決方案在現代醫療保健中的關鍵作用，並為市場的持續成長奠定了基礎。疾病盛行率的上升、技術的創新、人口結構的變化以及醫療實踐的演進，正共同推動著呼吸治療向以患者為中心的先進模式轉變，從而改善臨床療效，提高生活品質，並滿足全球醫療保健系統日益成長的需求。

儘管氧氣療法設備市場具有巨大的成長潛力，但仍面臨許多阻礙其擴張的重大挑戰。其中一個主要阻礙因素是政府部門實施的嚴格監管準則，這往往導致新產品核准流程漫長而複雜。雖然這些法規對於確保病患安全和設備有效性至關重要，但它們也延長了產品上市時間，並增加了額外的財務負擔，尤其對中小企業新興企業更是如此。

此外，氧氣療法高成本，主要原因是氧氣機設備複雜、維護要求高，以及某些地區報銷力度有限，這些因素進一步限制了氧氣治療的普及，尤其是在中低收入國家。這些因素共同構成了市場滲透的巨大障礙，迫使製造商專注於成本效益高的創新和合規策略，以在監管日益嚴格、成本意識日益增強的環境中維持成長。

氧氣療法設備市場區隔分析氧氣療法設備市場按產品類型、便攜性、應用、最終用戶和地區進行區隔。

北美將引領全球氧氣療法設備市場，預計到2024年將佔約42%的市場。北美氧氣療法設備市場的擴張受多種關鍵因素所驅動，其中最重要的是慢性呼吸系統疾病盛行率的上升。根據DelveInsight的分析（2024年），美國有超過3,550萬人患有慢性肺部疾病，包括氣喘和慢性阻塞性肺病（COPD）。其中，約有1,150萬成年人（占美國成年人口的4.6%）被診斷出患有COPD，包括慢性支氣管炎和肺氣腫。

這些進行性性呼吸系統疾病會損害肺功能，對患者、看護者和醫療保健系統造成沉重負擔。慢性阻塞性肺病（COPD）和氣喘率的上升直接推動了對先進氧氣療法解決方案的需求。慢性呼吸系統疾病患者通常需要長期吸氧，而對可靠的家用氧氣療法、攜帶式製氧機和智慧氧氣輸送設備的需求不斷成長，正在重塑市場趨勢。

氧氣療法設備的創新，例如整合人工智慧的製氧機、即時監測系統和攜帶式穿戴設備，正在提高患者的安全性、依從性和治療效果。這些解決方案能夠持續監測血氧水平、自動調節氧氣流量並實現遠端連接，確保患者獲得持續有效的治療，同時減輕醫護人員的負擔。

疾病流行率的上升，以及對呼吸系統研究和患者支持投入的不斷增加，正在塑造市場動態。諸如美國肺臟協會等組織持續加大研究經費投入，並推動旨在提高公眾對肺部疾病的認知、促進早期診斷和改善疾病管理的各項項目。這些努力透過教育病患、看護者和醫護人員如何正確使用、監測和堅持治療，來促進先進氧氣療法設備的普及應用。

因此，疾病高發生率、居家醫療的日益普及、技術創新、研究經費的增加以及患者支持計劃的擴大，預計將推動美國氧氣療法設備市場在 2025 年至 2032 年的預測期內持續成長。

歐洲氧氣療法設備市場的成長主要受癌症和心血管疾病等慢性病盛行率上升的推動，這些疾病需要透過氧氣療法設備反覆輸注藥物和液體。化療數量的增加以及兒科患者對氧療設備使用量的增加，也促進了市場擴張。

氧氣療法設備的科技進步，例如抗菌塗層導管和嵌入式感測器技術，提高了患者安全性，並減少了感染疾病和血栓症等併發症。這些創新，加上歐洲各地不斷增加的研究活動和臨床試驗，正在加速先進設備的應用。目前，短周邊靜脈導管在收入方面佔市場主導，但由於中線導管具有臨床優勢並能改善患者預後，因此它是成長最快的產品類別。

從區域來看，英國、德國、法國、西班牙和義大利等國家引領市場，其中英國預計將佔最大佔有率，這得益於其先進的醫療基礎設施和在研發方面的大量投入。醫療設備法規 (MDR) 的合規性以及新型治療方法的引入也在影響市場動態。此外，居家輸液治療和微創手術的顯著普及進一步推動了對先進血管通路和氧氣療法解決方案的需求。整體而言，歐洲市場呈現出需求穩定成長、技術持續創新以及醫療實踐不斷發展的平衡態勢。

亞太地區氧氣療法設備市場預計將在2025年至2032年間以9.27%的強勁複合年成長率成長。這個市場快速擴張的原因在於慢性阻塞性肺病（COPD）、氣喘和其他肺部疾病等慢性呼吸系統疾病的盛行率不斷上升，從而增加了對氧氣療法解決方案的需求。此外，該地區龐大且老化的人口也促進了市場成長，因為老年人更有可能需要長期氧氣療法。印度、中國和日本等國家是主要市場，其中印度預計將實現最高的成長率。

儘管目前固定式和攜帶式氧氣濃縮器仍佔市場主導地位，但攜帶式和穿戴式式製氧機因其便利性和對居家照護的適應性而成長最快。醫療基礎設施的持續發展、政府旨在改善醫療設備可近性的舉措以及不斷成長的醫療費用支出也推動了市場擴張。多家區域性和全球性公司正積極投資研發和新產品推出，以推動技術創新並提高設備效率。

此外，患者友善、微創氧氣輸送系統的日益普及，以及智慧監測和人工智慧功能的不斷融合，正在推動市場成長。因此，亞太地區憑藉著不斷擴大的患者群體、日益完善的醫療基礎設施以及氧氣療法設備的持續創新，成為全球成長最快的市場。

以下是氧氣療法設備市場的主要企業，它們合計佔最大的市場佔有率，並主導產業趨勢：

  • Koninklijke Philips NV
  • Invacare Corporation
  • Inogen, Inc.
  • Dragerwerk AG & Co. KgaA
  • ICU Medical, Inc.
  • CAIRE Inc.
  • Fisher & Paykel Healthcare Limited
  • Armstrong Medical
  • Vyaire Medical, Inc.
  • Hamilton Medical
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • BMC Medical Co., Ltd.
  • Allied Medical Limited
  • Teleflex Incorporated
  • HERSILL
  • Chart Industries, Inc.
  • DeVilbiss Healthcare LLC
  • GCE Group
  • Oxygen Solutions Inc.
  • Besco Medical Limited

氧氣療法設備市場的競爭格局呈現出成熟全球企業與新興創新者並存的局面。該市場高度集中，飛利浦偉康 (Philips Respironics)、Inogen、CAIRE、林德醫療 (Linde Healthcare) 和瑞思邁 (ResMed) 等主要企業佔著顯著的市場佔有率，尤其是在高科技固定式和攜帶式氧氣濃縮機、液氧系統和先進的輸氧介面領域。這些領導企業憑藉持續的研發投入、強大的品牌知名度和多元化的產品系列保持著競爭優勢，其產品組合能夠滿足包括醫院、居家照護和長期護理機構在內的各種呼吸護理需求。

同時，一些規模小、反應敏捷的公司和Start-Ups正透過推出創新解決方案和智慧氧氣療法技術來重塑市場格局。許多新晉參與企業正在推動新興領域的成長，例如人工智慧驅動的監測系統、攜帶式和穿戴式式製氧機，以及旨在實現更互聯、更人性化的患者設備。透過實現即時監測、自動氧氣輸送調節和遠端系統管理，這些企業正在幫助患者從以醫院為基礎的治療模式轉向更靈活的家庭和門診呼吸照護模式。

現有企業與創新新進者之間的這種互動，孕育了一個以技術快速進步和策略聯盟為特徵的競爭環境。領先企業積極尋求合作、收購和技術整合，以提高設備效率、拓展產品系列併維持市場領先地位。因此，競爭不僅推動了創新和患者療效的提升，也加速了便利、高效且以患者為中心的氧氣療法方案在全球的普及。

氧氣療法設備市場最新發展動態

  • 2025 年 6 月，專注於居家醫療先進呼吸解決方案的領先醫療技術公司 Inogen, Inc. 宣布推出 Voxi™ 5，這是一款新型固定式氧氣濃縮器(SOC)，旨在改善美國長期護理患者獲得高品質氧氣療法的機會。這款新產品豐富了 Inogen 的產品線，完善了其攜帶式氧氣濃縮機產品組合，擴大了市場機會，並充分利用了其已建立的分銷和銷售管道。
  • 2025 年 6 月，全球呼吸照護公司 VARON 正式推出專為墨西哥市場設計的新平台，以應對該國慢性呼吸系統疾病數量的成長，使得提供可靠的家庭氧氣療法成為醫療優先事項。
  • 2025 年 1 月，Caire 宣布推出其新型固定式氧氣濃縮器IntenOxy 5。該公司表示，該產品目前已在美國和波多黎各上市，並計劃在不久的將來將銷售範圍擴大到加拿大。

氧氣療法設備市場區隔

  • 按產品類型分類的氧氣療法設備趨勢
  • 系統
  • 高流量氧氣鼻管氧氣療法（HFNO）裝置
  • 氧氣濃縮機
  • 人工呼吸器
  • 其他
  • 一次性用品和配件
  • 氧氣罩
  • 氧氣鼻管
  • 人工呼吸袋
  • 其他
  • 按便攜性分類的氧氣療法設備發展趨勢
  • 固定式
  • 便攜的
  • 氧氣療法設備的用途和使用環境
  • 慢性阻塞性肺病
  • 氣喘
  • 呼吸窘迫症候群
  • 其他
  • 氧氣療法設備終端用戶趨勢
  • 醫院和診所
  • 門診手術中心
  • 居家醫療環境
  • 其他
  • 氧氣療法設備的區域趨勢
  • 北美氧氣療法設備市場
  • 美國氧氣療法設備市場
  • 加拿大氧氣療法設備市場
  • 墨西哥氧氣療法設備市場
  • 歐洲氧氣療法設備市場
  • 英國氧氣療法設備市場
  • 德國氧氣療法設備市場
  • 法國氧氣療法設備市場
  • 義大利氧氣療法設備市場
  • 西班牙氧氣療法設備市場
  • 其他歐洲氧氣療法設備市場
  • 亞太地區氧氣療法設備市場
  • 中國氧氣療法設備市場
  • 日本氧氣療法設備市場
  • 印度氧氣療法設備市場
  • 澳洲氧氣療法設備市場
  • 韓國氧氣療法設備市場
  • 亞太地區其他氧氣療法設備市場
  • 世界其他地區氧氣療法設備市場
  • 南美洲氧氣療法設備市場
  • 中東氧氣療法設備市場
  • 非洲氧氣療法設備市場

影響分析：人工智慧的創新與應用：

人工智慧正透過提供更智慧、更個人化、更有效率的呼吸照護解決方案，迅速改變氧氣療法設備市場。人工智慧驅動的氧氣濃縮機和輸送系統可以即時監測患者的血氧飽和度，分析其變化趨勢，並自動調節流量以維持最佳血氧水平。這些智慧系統能夠改善治療效果，並降低高氧血症和低氧血症的風險，這對於慢性呼吸系統疾病患者尤其重要。

除了自動調節流量外，人工智慧整合還支援遠端監控和預測性維護，使醫護人員能夠追蹤患者依從性、檢測異常情況並在設備故障發生前進行預測。機器學習演算法還能分析多名患者的大型資料集，以識別治療模式、最佳化治療通訊協定並輔助臨床決策。此外，人工智慧解決方案透過提供語音控制、行動應用整合以及低電量或氧氣供應中斷的即時警報，提升了攜帶式氧氣設備的便利性。透過這些方式，人工智慧創新正在改善患者安全、治療效果以及家庭和臨床環境中氧氣療法的可近性。

美國關稅對氧氣療法設備市場的影響分析：

美國對進口醫療設備和原料加徵關稅，對氧氣療法設備市場產生了複雜的影響。雖然關稅的整體意圖是鼓勵國內生產，減少對外國供應鏈的依賴，但也給整個價值鏈帶來了成本壓力。許多氧氣濃縮機、氣瓶、閥門、壓縮機、感測器和其他組件都來自國際供應商，或由這些供應商組裝，尤其是在中國、德國和日本。對這些進口組件徵收關稅可能會增加美國製造商的生產成本，進而導致終端用戶價格上漲，並增加醫療機構和居家病患的負擔。

新冠疫情期間，美國曾暫時降低部分醫療設備的關稅，以防止氧氣供應中斷。但由於貿易摩擦持續不斷，長期關稅結構仍不明朗。製造商正採取措施抵消不斷上漲的進口關稅，例如供應鏈多元化、生產在地化以及投資自動化。然而，中小企業應對這些額外成本的能力有限，利潤率面臨壓力。

另一方面，關稅也起到了促進國內創新和推動氧氣療法設備關鍵製造流程（尤其是過濾器和感測器等關鍵零件）回流的作用。因此，儘管關稅會透過增加製造成本和物流成本帶來短期挑戰，但從長遠來看，它可能有助於增強美國氧氣療法設備市場的韌性和技術獨立性。

目錄

第1章氧氣療法設備市場報告概述

  • 調查範圍
  • 市場區隔
  • 市場假設

第2章氧氣療法設備市場摘要整理

  • 市場概覽

第3章氧氣療法設備市場關鍵因素分析

  • 市場促進因素
    • 呼吸系統疾病增加
    • 這些設備在加護治療中的重要用途
    • 產品開發中的快速創新
  • 市場阻礙與課題
    • 嚴格的政府監管準則延緩了產品核准。
    • 醫療成本不斷上漲
  • 市場機遇
    • 新興市場尚未開發的潛力
    • 提高人們對氧氣療法的認知

第4章 影響分析

  • 人工智慧驅動的創新和應用
  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章氧氣療法設備市場：波特五力分析

第7章氧氣療法設備市場評估

  • 依產品類型
    • 系統
    • 一次性產品及配件
  • 透過便攜性
    • 固定式
    • 可攜式的
  • 透過使用
    • COPD
    • 氣喘
    • 呼吸窘迫症候群
    • 其他
  • 最終用戶
    • 醫院和診所
    • 門診手術中心
    • 居家照護
  • 按地區
    • 北美洲
    • 歐洲
    • 亞太地區
    • 其他地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

第10章氧氣療法設備市場公司及產品概況

  • Koninklijke Philips NV
  • Invacare Corporation
  • Inogen, Inc.
  • Dragerwerk AG & Co. KgaA
  • ICU Medical, Inc.
  • CAIRE Inc.
  • Fisher & Paykel Healthcare Limited
  • Armstrong Medical
  • Vyaire Medical, Inc.
  • Hamilton Medical
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • BMC Medical Co., Ltd.
  • Allied Medical Limited
  • Teleflex Incorporated
  • HERSILL
  • Chart Industries, Inc.
  • DeVilbiss Healthcare LLC
  • GCE Group
  • Oxygen Solutions Inc.
  • Besco Medical Limited

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0478

Oxygen Therapy Equipment Market Summary

  • The global oxygen therapy equipment market is expected to increase from USD 3,295.77 million in 2024 to USD 5,866.74 million by 2032, reflecting strong and sustained growth.
  • The global oxygen therapy equipment market is growing at a CAGR of 7.52% during the forecast period from 2025 to 2032.
  • The global oxygen therapy equipment market is witnessing robust growth driven by the rising prevalence of respiratory diseases, expanding use in critical care, and rapid technological advancements. Increasing cases of COPD, asthma, and other chronic lung conditions have heightened the demand for continuous oxygen support in both hospitals and home care settings. In critical care units, oxygen devices are indispensable for managing patients with severe respiratory or cardiac complications. Simultaneously, innovations such as AI-integrated concentrators, real-time monitoring, and portable designs are improving treatment precision and patient convenience. Together, these factors are fueling widespread adoption and strengthening the market's growth trajectory.
  • The leading companies operating in the oxygen therapy equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Dragerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited, and others.
  • North America holds the highest share in the global oxygen therapy equipment market, driven by a well-established healthcare infrastructure, a high prevalence of chronic respiratory and other chronic diseases, and a growing aging population. The region's advanced adoption of medical technologies, including portable and stationary oxygen concentrators, AI-integrated monitoring systems, and smart oxygen delivery devices, further reinforces its market dominance. Rising demand for home-based oxygen therapy, coupled with continuous technological innovation and supportive patient programs, is accelerating adoption and ensuring sustained growth. These factors collectively position North America as a leading and highly influential market in the global oxygen therapy equipment landscape.
  • Within the product type segment of the oxygen therapy equipment market, the system catheters category is projected to hold the largest share in 2024.

Factors Contributing to the Growth of the Oxygen Therapy Equipment Market

  • Increase in the Cases of Respiratory Disorders Leading to Surge in the Oxygen Therapy Equipment Market: The increasing prevalence of chronic and acute respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, and pneumonia, is one of the primary drivers of the oxygen therapy equipment market. According to the World Health Organization (WHO), COPD remains a leading cause of morbidity and mortality worldwide, particularly in aging populations and regions with high air pollution levels. The growing number of patients suffering from respiratory insufficiency and hypoxemia has significantly elevated the demand for oxygen concentrators, cylinders, and portable oxygen devices. Moreover, lifestyle factors such as smoking, occupational exposure to harmful gases, and urban pollution are contributing to rising respiratory complications, leading to higher oxygen therapy adoption in both clinical and home care settings. This surge in disease burden continues to propel the market forward as healthcare systems prioritize long-term respiratory support solutions.
  • Significant Usage of These Devices in Critical Care: Oxygen therapy equipment plays a vital role in critical care environments, where maintaining optimal oxygen levels is essential for survival and recovery. Hospitals and intensive care units (ICUs) increasingly rely on advanced oxygen delivery systems for managing patients with severe respiratory distress, postoperative complications, and cardiac conditions. The growing incidence of emergency admissions due to respiratory failure, trauma, or sepsis further drives demand for high-performance stationary concentrators, ventilators, and oxygen delivery interfaces. Additionally, advancements in monitoring technologies and integrated oxygen flow systems enable clinicians to deliver precise oxygen concentrations, improving patient outcomes. With the expansion of critical care infrastructure and a growing emphasis on advanced respiratory support, the use of oxygen therapy equipment in acute settings continues to strengthen the market globally.
  • Rapid Technical Innovation in Product Development: Continuous technological innovation is transforming the oxygen therapy equipment landscape by improving portability, efficiency, and patient comfort. Modern oxygen concentrators now feature compact designs, longer battery life, automated flow adjustment, and smart connectivity that allows remote monitoring and control. The integration of artificial intelligence (AI) and Internet of Things (IoT) technologies enables real-time tracking of oxygen usage and patient vitals, optimizing treatment adherence and clinical decision-making. Furthermore, manufacturers are introducing noise-reduction systems, lightweight materials, and user-friendly interfaces to enhance patient experience, particularly in home care settings. These innovations are expanding accessibility to oxygen therapy beyond hospitals, empowering patients to manage chronic respiratory conditions independently. As a result, rapid product advancements are driving wider adoption and sustaining the long-term growth trajectory of the oxygen therapy equipment market.

Oxygen Therapy Equipment Market Report Segmentation

This oxygen therapy equipment market report offers a comprehensive overview of the global oxygen therapy equipment market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation By Product Type (Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, and Others] and Disposables and Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, and Others]), Portability (Stationary and Portable), Application (COPD, Asthma, Respiratory Distress Syndrome, and Others), End-Users (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing Oxygen Therapy Equipment market.

The oxygen therapy equipment refers to medical devices designed to deliver supplemental oxygen to individuals with respiratory disorders or conditions that cause low blood oxygen levels. These devices include oxygen concentrators, cylinders, liquid oxygen systems, and delivery interfaces such as masks, nasal cannulas, and ventilators. They are used across hospitals, clinics, and home care settings to support patients with chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary conditions, helping maintain adequate oxygen saturation and improve overall respiratory function.

The growth of the oxygen therapy equipment market is being strongly driven by the rising incidence of respiratory conditions, the increasing use of these devices in critical care, and rapid technological innovations in product development. The growing prevalence of chronic respiratory diseases such as COPD, asthma, and sleep apnea, coupled with environmental factors like air pollution and smoking, has significantly increased the demand for oxygen therapy solutions across both hospital and home care settings. In critical care environments, oxygen therapy equipment plays a vital role in stabilizing patients suffering from respiratory distress, cardiac complications, and postoperative conditions, driving adoption in ICUs and emergency departments. Meanwhile, rapid advancements in device technology, including the development of compact, energy-efficient, and AI-integrated concentrators, are enhancing treatment accuracy, patient comfort, and mobility. Features such as real-time oxygen monitoring, automated flow adjustment, and wireless connectivity are making oxygen therapy more accessible and user-friendly, especially for long-term home use. Collectively, these factors are reinforcing the market's expansion by aligning technological progress with the growing clinical and home-based demand for reliable respiratory support solutions.

What are the latest Oxygen Therapy Equipment Market Dynamics and Trends?

The global oxygen therapy equipment market is witnessing strong and sustained growth, driven by a combination of clinical, demographic, environmental, and technological factors. The rising prevalence of chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (COPD) represents a major growth driver.

According to DelveInsight analysis (2025), over 250 million people globally are living with asthma, making it one of the most widespread chronic conditions across all age groups, while COPD cases are projected to reach 600 million by 2050. Environmental factors, including escalating air pollution, widespread tobacco use, climate change, occupational hazards, and rapid urbanization, have further contributed to the surge in respiratory ailments. In parallel, the expanding geriatric population, which is more vulnerable to chronic illnesses and repeated hospitalizations, is creating additional demand for oxygen therapy equipment across hospitals, critical care units, outpatient facilities, and home care settings.

The growing need for continuous oxygen support in critical care environments, where patients with severe respiratory distress, cardiac complications, or post-surgical conditions require reliable oxygen delivery, is further driving market adoption. At the same time, rapid technological advancements are transforming the sector. Innovations such as portable and stationary oxygen concentrators, AI-integrated monitoring systems, smart delivery devices, and user-friendly interfaces are enhancing treatment precision, improving patient comfort, and promoting adherence to therapy. The increasing focus on home-based care solutions, enabled by portable and connected devices, is also expanding access and convenience for patients managing long-term respiratory conditions.

Supportive regulatory frameworks, growing awareness about early diagnosis and timely intervention, and initiatives to improve patient education are further accelerating the adoption of oxygen therapy equipment. Collectively, these factors underscore the critical role of oxygen therapy solutions in modern healthcare, positioning the market for sustained growth. The convergence of rising disease prevalence, technological innovation, demographic shifts, and evolving care practices is driving a transformative shift toward advanced, patient-centric respiratory therapies that enhance clinical outcomes, improve quality of life, and meet the increasing demands of healthcare systems worldwide.

Despite strong growth potential, the oxygen therapy equipment market faces several key challenges that hinder its expansion. One major restraint is the presence of strict regulatory guidelines imposed by government authorities, which often result in lengthy and complex approval processes for new products. These regulations, while essential for ensuring patient safety and device efficacy, increase the time-to-market and impose additional financial burdens on manufacturers, particularly smaller or emerging companies.

In addition, the high cost of oxygen therapy, driven by advanced concentrators, maintenance requirements, and limited reimbursement support in certain regions, further restricts accessibility, especially in low- and middle-income countries. Together, these factors create significant barriers to market penetration, compelling manufacturers to focus on cost-effective innovations and compliance strategies to sustain growth in an increasingly regulated and cost-sensitive environment.

Oxygen Therapy Equipment Market Segment Analysis

Oxygen Therapy Equipment Market by Product Type (Systems [HFNO (High-Flow Nasal Cannula Oxygenation) Devices, Oxygen Concentrators, Ventilators, and Others] and Disposables and Accessories [Oxygen Masks, Nasal Cannulas, Resuscitator Bags, and Others]), Portability (Stationary and Portable), Application (COPD, Asthma, Respiratory Distress Syndrome, and Others), End-Users (Hospitals and Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

Oxygen Therapy Equipment Market Regional Analysis

North America Oxygen Therapy Equipment Market Trends

North America, led by the United States, dominates the global oxygen therapy equipment market, accounting for approximately 42% of the total market share in 2024. The expansion of the North America oxygen therapy equipment market is being driven by several critical factors, foremost among them the rising prevalence of chronic respiratory diseases. According to the DelveInsight analysis (2024), more than 35.5 million people in the U.S. live with chronic lung conditions, including asthma and chronic obstructive pulmonary disease (COPD). Within this population, approximately 11.5 million adults, representing 4.6% of the U.S. adult population, have been diagnosed with COPD, encompassing chronic bronchitis and emphysema.

These progressive respiratory conditions impair pulmonary function and place a substantial burden on patients, caregivers, and the healthcare system. The rising incidence of COPD and asthma is directly accelerating demand for advanced oxygen therapy solutions. Patients with chronic respiratory conditions often require long-term supplemental oxygen, and the increasing need for reliable home-based oxygen therapy, portable concentrators, and smart oxygen delivery devices is reshaping market demand.

Technological innovations in oxygen therapy equipment, such as AI-integrated concentrators, real-time monitoring systems, and portable wearable devices, are enhancing patient safety, adherence, and treatment efficacy. These solutions enable continuous monitoring of blood oxygen levels, automated oxygen flow adjustments, and remote connectivity, ensuring patients receive consistent and effective therapy while reducing healthcare burdens.

In addition to disease prevalence, increased investment in respiratory research and patient support is shaping market dynamics. Organizations such as the American Lung Association continue to expand research funding and programs to improve awareness, early diagnosis, and management of lung diseases. These initiatives support the adoption of advanced oxygen therapy devices by educating patients, caregivers, and healthcare providers on proper usage, monitoring, and adherence.

Therefore, the combination of high disease prevalence, growing home healthcare adoption, technological innovation, increased research funding, and supportive patient programs is expected to drive sustained growth in the U.S. oxygen therapy equipment market over the forecast period from 2025 to 2032.

Europe Oxygen Therapy Equipment Market Trends

The growth of the European oxygen therapy equipment market is driven primarily by the rising prevalence of chronic diseases such as cancer and cardiovascular conditions, which necessitate repeated administration of medications and fluids through oxygen therapy devices. The increasing number of chemotherapy treatments, along with the growing utilization of these devices in pediatric patients, further contributes to market expansion.

Technological advancements in oxygen therapy equipment, including antimicrobial-coated catheters and sensor-enabled technologies, are improving patient safety and reducing complications such as infections and thrombosis. These innovations, combined with increased research activities and clinical trials across Europe, are accelerating the adoption of advanced devices. Currently, short peripheral intravenous catheters dominate the market in terms of revenue, while midline catheters represent the fastest-growing product segment due to their clinical advantages and improved patient outcomes.

Geographically, countries such as the United Kingdom, Germany, France, Spain, and Italy lead the market, with the UK expected to hold the largest share thanks to its advanced healthcare infrastructure and substantial investments in research and development. Regulatory compliance with the EU Medical Device Regulation (MDR) and the adoption of novel therapeutic approaches are also shaping market dynamics. Additionally, a noticeable shift toward home-infusion therapies and minimally invasive procedures is driving further demand for advanced vascular access and oxygen therapy solutions. Overall, the market reflects a balance of steady demand growth, continuous technological innovation, and evolving healthcare practices across Europe.

Asia-Pacific Oxygen Therapy Equipment Market Trends

The Asia-Pacific oxygen therapy equipment market is experiencing strong growth momentum, projected to register a 9.27% CAGR from 2025 to 2032. The market is expanding rapidly due to the rising prevalence of chronic respiratory diseases such as chronic obstructive pulmonary disease (COPD), asthma, and other pulmonary disorders, which increase the demand for oxygen therapy solutions. The region's large and aging population further contributes to market growth, as older adults are more likely to require long-term oxygen therapy. Countries such as India, China, and Japan are key markets, with India expected to register the highest growth rate.

Stationary and portable oxygen concentrators currently dominate the product segment, while portable and wearable devices are the fastest-growing due to their convenience and suitability for home-based care. Market expansion is also supported by ongoing healthcare infrastructure development, government initiatives to improve access to medical devices, and rising healthcare expenditure. Several regional and global players are actively investing in research and new product launches, driving technological advancements and improving device efficiency.

Additionally, increasing adoption of patient-friendly, minimally invasive oxygen delivery systems and the integration of smart monitoring and AI-powered features are shaping the market's upward trajectory. Thus, the Asia-Pacific region stands out as the fastest-growing market globally, driven by expanding patient populations, enhanced healthcare infrastructure, and continuous innovation in oxygen therapy equipment.

Who are the major players in the Oxygen Therapy Equipment Market?

The following are the leading companies in the oxygen therapy equipment market. These companies collectively hold the largest market share and dictate industry trends.

  • Koninklijke Philips N.V.
  • Invacare Corporation
  • Inogen, Inc.
  • Dragerwerk AG & Co. KgaA
  • ICU Medical, Inc.
  • CAIRE Inc.
  • Fisher & Paykel Healthcare Limited
  • Armstrong Medical
  • Vyaire Medical, Inc.
  • Hamilton Medical
  • Shenzhen Comen Medical Instruments Co., Ltd.
  • BMC Medical Co., Ltd.
  • Allied Medical Limited
  • Teleflex Incorporated
  • HERSILL
  • Chart Industries, Inc.
  • DeVilbiss Healthcare LLC
  • GCE Group
  • Oxygen Solutions Inc.
  • Besco Medical Limited

How is the competitive landscape shaping the Oxygen Therapy Equipment Market?

The competitive landscape of the oxygen therapy equipment market reflects a balance between established global corporations and emerging innovators. The market is highly consolidated, with major players such as Philips Respironics, Inogen, CAIRE Inc., Linde Healthcare, and ResMed holding significant market share, particularly in high-tech stationary and portable oxygen concentrators, liquid oxygen systems, and advanced delivery interfaces. These leaders maintain their dominance through continuous research and development, strong brand recognition, and diversified product portfolios that cater to a wide range of respiratory care needs across hospitals, home care, and long-term care settings.

At the same time, smaller, agile companies and startups are reshaping the market by introducing innovative solutions and smart oxygen therapy technologies. Many of these new entrants are driving growth in emerging segments, including AI-powered monitoring systems, portable and wearable concentrators, and devices with enhanced connectivity and patient-friendly designs. By enabling real-time monitoring, automated oxygen delivery adjustments, and remote management, they are supporting a shift from hospital-centric care to more flexible, home-based, and outpatient respiratory care.

This interplay between established incumbents and innovative disruptors is fostering a competitive environment characterized by rapid technological advancement and strategic collaborations. Larger corporations are increasingly engaging in partnerships, acquisitions, and technology integrations to enhance device efficiency, expand product portfolios, and maintain market leadership. As a result, competition is driving not only innovation and improved patient outcomes but also accelerating the adoption of more convenient, efficient, and patient-centric oxygen therapy solutions worldwide.

Recent Developmental Activities in the Oxygen Therapy Equipment Market

  • In June 2025, Inogen, Inc., a prominent medical technology company focused on advanced respiratory solutions for home care, unveiled the Voxi(TM) 5, a new stationary oxygen concentrator (SOC) aimed at improving access to high-quality oxygen therapy for long-term care patients in the United States. This latest addition to Inogen's product lineup complements its range of portable oxygen concentrators, broadening market opportunities and capitalizing on the company's established distribution and sales channels.
  • In June 2025, VARON, a global respiratory care company, officially introduced a new platform specifically designed for the Mexican market, responding to the growing healthcare priority of providing reliable home oxygen therapy amid rising chronic respiratory conditions in the country.
  • In January 2025, Caire announced the launch of its new IntenOxy 5 stationary oxygen concentrator. According to the company, the device is now available for purchase in the United States and Puerto Rico, with plans to expand availability to Canada in the near future.

Oxygen Therapy Equipment Market Segmentation

  • Oxygen Therapy Equipment Product Type Exposure
  • Systems
  • HFNO (High-Flow Nasal Cannula Oxygenation) Devices
  • Oxygen Concentrators
  • Ventilators
  • Others
  • Disposables and Accessories
  • Oxygen Masks
  • Nasal Cannulas
  • Resuscitator Bags
  • Others
  • Oxygen Therapy Equipment Portability Exposure
  • Stationary
  • Portable
  • Oxygen Therapy Equipment Application Exposure
  • COPD
  • Asthma
  • Respiratory Distress Syndrome
  • Others
  • Oxygen Therapy Equipment End-Users Exposure
  • Hospitals and Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings
  • Others
  • Oxygen Therapy Equipment Geography Exposure
  • North America Oxygen Therapy Equipments Market
  • United States Oxygen Therapy Equipments Market
  • Canada Oxygen Therapy Equipments Market
  • Mexico Oxygen Therapy Equipments Market
  • Europe Oxygen Therapy Equipments Market
  • United Kingdom Oxygen Therapy Equipments Market
  • Germany Oxygen Therapy Equipments Market
  • France Oxygen Therapy Equipments Market
  • Italy Oxygen Therapy Equipments Market
  • Spain Oxygen Therapy Equipments Market
  • Rest of Europe Oxygen Therapy Equipments Market
  • Asia-Pacific Oxygen Therapy Equipments Market
  • China Oxygen Therapy Equipments Market
  • Japan Oxygen Therapy Equipments Market
  • India Oxygen Therapy Equipments Market
  • Australia Oxygen Therapy Equipments Market
  • South Korea Oxygen Therapy Equipments Market
  • Rest of Asia-Pacific Oxygen Therapy Equipments Market
  • Rest of the World Oxygen Therapy Equipments Market
  • South America Oxygen Therapy Equipments Market
  • Middle East Oxygen Therapy Equipments Market
  • Africa Oxygen Therapy Equipments Market

Impact Analysis

AI-Powered Innovations and Applications:

Artificial intelligence is rapidly transforming the oxygen therapy equipment market by enabling smarter, more personalized, and efficient respiratory care solutions. AI-powered oxygen concentrators and delivery systems can monitor a patient's oxygen saturation in real time, analyze trends, and automatically adjust flow rates to maintain optimal blood oxygen levels. These intelligent systems improve therapeutic outcomes and reduce the risk of over- or under-oxygenation, which is particularly critical for patients with chronic respiratory conditions.

Beyond automated flow regulation, AI integration facilitates remote monitoring and predictive maintenance, allowing healthcare providers to track patient compliance, detect anomalies, and anticipate device malfunctions before they occur. Machine learning algorithms can also analyze large datasets from multiple patients to identify patterns, optimize treatment protocols, and support clinical decision-making. Additionally, AI-driven solutions are enhancing the usability of portable oxygen devices, providing voice-assisted controls, mobile app connectivity, and real-time alerts for low battery or depleted oxygen supply. Thus, AI innovations are improving patient safety, treatment effectiveness, and the accessibility of oxygen therapy in both home and clinical settings.

U.S. Tariff Impact Analysis on the Oxygen Therapy Equipment Market:

The imposition of U.S. tariffs on imported medical devices and raw materials has had a mixed impact on the oxygen therapy equipment market. While the broader intent of tariffs is to encourage domestic manufacturing and reduce reliance on foreign supply chains, they have also led to cost pressures across the value chain. Many oxygen concentrators, cylinders, and parts such as valves, compressors, and sensors are sourced or assembled from international suppliers, particularly in China, Germany, and Japan. Tariffs on these imported components have increased production costs for U.S.-based manufacturers, resulting in higher end-user prices and potentially limiting affordability for healthcare providers and home care patients.

During the COVID-19 pandemic, the United States temporarily eased certain medical device tariffs to ensure an uninterrupted oxygen supply, but as trade tensions continue, the long-term tariff structure remains uncertain. Manufacturers have responded by diversifying supply chains, localizing production, and investing in automation to offset higher import duties. However, smaller and mid-sized companies face tighter profit margins due to limited capacity to absorb these added costs.

On the positive side, tariffs have encouraged domestic innovation and the reshoring of key oxygen therapy device manufacturing, particularly in critical components like filters and sensors. Therefore, while tariffs create short-term challenges through increased manufacturing and logistics costs, they may support long-term resilience and technological self-reliance within the U.S. oxygen therapy equipment market.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the Oxygen Therapy Equipment market report study

  • Market size analysis for the current oxygen therapy equipment market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the oxygen therapy equipment market.
  • Various opportunities available for the other competitors in the oxygen therapy equipment market.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current oxygen therapy equipment market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the oxygen therapy equipment market growth in the future?

Frequently Asked Questions for the Oxygen Therapy Equipment Market

1. What is the growth rate of the oxygen therapy equipment market?

  • The oxygen therapy equipment market is estimated to grow at a CAGR of 7.52% during the forecast period from 2025 to 2032.

2. What is the market for oxygen therapy equipment?

  • The oxygen therapy equipment market was valued at USD 3,295.77 million in 2024 and is expected to reach USD 5,866.74 million by 2032.

3. Which region has the highest share in the oxygen therapy equipment market?

  • North America holds the highest share in the global oxygen therapy equipment market, driven by a well-established healthcare infrastructure, a high prevalence of chronic respiratory and other chronic diseases, and a growing aging population. The region's advanced adoption of medical technologies, including portable and stationary oxygen concentrators, AI-integrated monitoring systems, and smart oxygen delivery devices, further reinforces its market dominance. Rising demand for home-based oxygen therapy, coupled with continuous technological innovation and supportive patient programs, is accelerating adoption and ensuring sustained growth. These factors collectively position North America as a leading and highly influential market in the global oxygen therapy equipment landscape.

4. What are the drivers for the oxygen therapy equipment market?

  • The global oxygen therapy equipment market is witnessing robust growth driven by the rising prevalence of respiratory diseases, expanding use in critical care, and rapid technological advancements. Increasing cases of COPD, asthma, and other chronic lung conditions have heightened the demand for continuous oxygen support in both hospitals and home care settings. In critical care units, oxygen devices are indispensable for managing patients with severe respiratory or cardiac complications. Simultaneously, innovations such as AI-integrated concentrators, real-time monitoring, and portable designs are improving treatment precision and patient convenience. Together, these factors are fueling widespread adoption and strengthening the market's growth trajectory.

5. Who are the key players operating in the oxygen therapy equipment market?

  • Some of the key market players operating in the oxygen therapy equipment market include Koninklijke Philips N.V., Invacare Corporation, Inogen, Inc., Dragerwerk AG & Co. KgaA, ICU Medical, Inc., CAIRE Inc., Fisher & Paykel Healthcare Limited, Armstrong Medical, Vyaire Medical, Inc., Hamilton Medical, Shenzhen Comen Medical Instruments Co., Ltd., BMC Medical Co., Ltd., Allied Medical Limited, Teleflex Incorporated, HERSILL, Chart Industries, Inc., DeVilbiss Healthcare LLC, GCE Group, Oxygen Solutions Inc., Besco Medical Limited, and Others.

Table of Contents

1. Oxygen Therapy Equipment Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Oxygen Therapy Equipment Market Executive Summary

  • 2.1 Market at Glance

3. Oxygen Therapy Equipment Market Key Factors Analysis

  • 3.1 Oxygen Therapy Equipment Market Drivers
    • 3.1.1 Increase in the cases of respiratory disorders
    • 3.1.2 Significant usage of these devices in critical care
    • 3.1.3 Rapid technical innovation in product development
  • 3.2 Oxygen Therapy Equipment Market Restraints and Challenges
    • 3.2.1 Strict regulatory guidelines by the government are causing delays in product approvals
    • 3.2.2 The high cost of therapy
  • 3.3 Oxygen Therapy Equipment Market Opportunity
    • 3.3.1 Untapped potential of emerging markets
    • 3.3.2 Increasing awareness regarding oxygen therapy

4. Impact Analysis

  • 4.1 AI-Powered Innovations and Applications
  • 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Oxygen Therapy Equipment Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Oxygen Therapy Equipment Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Systems
      • 7.1.1.1 HFNO (High-Flow Nasal Cannula Oxygenation) Devices
      • 7.1.1.2 Oxygen Concentrators
      • 7.1.1.3 Ventilators
      • 7.1.1.4 Others
    • 7.1.2 Disposables and Accessories
      • 7.1.2.1 Oxygen Masks
      • 7.1.2.2 Nasal Cannulas
      • 7.1.2.3 Resuscitator Bags
      • 7.1.2.4 Others
  • 7.2 By Portability
    • 7.2.1 Stationary
    • 7.2.2 Portable
  • 7.3 By Applications
    • 7.3.1 COPD
    • 7.3.2 Asthma
    • 7.3.3 Respiratory Distress Syndrome
    • 7.3.4 Others
  • 7.4 By End-Users
    • 7.4.1 Hospitals and Clinics
    • 7.4.2 Ambulatory Surgical Centers
    • 7.4.3 Home Care Settings
    • 7.4.4 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.1.2 Canada Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.1.3 Mexico Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.2 Europe
      • 7.5.2.1 France Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.2 Germany Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.3 United Kingdom Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.4 Italy Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.5 Spain Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.2.6 Rest of Europe Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.2 Japan Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.3 India Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.4 Australia Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.5 South Korea Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.3.6 Rest of Asia-Pacific Oxygen Therapy Equipment Market Size in USD million (2022-2032)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1 Middle East Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.4.2 Africa Oxygen Therapy Equipment Market Size in USD million (2022-2032)
      • 7.5.4.3 South America Oxygen Therapy Equipment Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Oxygen Therapy Equipment Market Company and Product Profiles

  • 10.1 Koninklijke Philips N.V.
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Invacare Corporation
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Inogen, Inc.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Dragerwerk AG & Co. KgaA
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 ICU Medical, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 CAIRE Inc.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 Fisher & Paykel Healthcare Limited
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Armstrong Medical
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Vyaire Medical, Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Hamilton Medical
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Shenzhen Comen Medical Instruments Co., Ltd.
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 BMC Medical Co., Ltd.
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy
  • 10.13 Allied Medical Limited
    • 10.13.1 Company Overview
    • 10.13.2 Company Snapshot
    • 10.13.3 Financial Overview
    • 10.13.4 Product Listing
    • 10.13.5 Entropy
  • 10.14 Teleflex Incorporated
    • 10.14.1 Company Overview
    • 10.14.2 Company Snapshot
    • 10.14.3 Financial Overview
    • 10.14.4 Product Listing
    • 10.14.5 Entropy
  • 10.15 HERSILL
    • 10.15.1 Company Overview
    • 10.15.2 Company Snapshot
    • 10.15.3 Financial Overview
    • 10.15.4 Product Listing
    • 10.15.5 Entropy
  • 10.16 Chart Industries, Inc.
    • 10.16.1 Company Overview
    • 10.16.2 Company Snapshot
    • 10.16.3 Financial Overview
    • 10.16.4 Product Listing
    • 10.16.5 Entropy
  • 10.17 DeVilbiss Healthcare LLC
    • 10.17.1 Company Overview
    • 10.17.2 Company Snapshot
    • 10.17.3 Financial Overview
    • 10.17.4 Product Listing
    • 10.17.5 Entropy
  • 10.18 GCE Group
    • 10.18.1 Company Overview
    • 10.18.2 Company Snapshot
    • 10.18.3 Financial Overview
    • 10.18.4 Product Listing
    • 10.18.5 Entropy
  • 10.19 Oxygen Solutions Inc.
    • 10.19.1 Company Overview
    • 10.19.2 Company Snapshot
    • 10.19.3 Financial Overview
    • 10.19.4 Product Listing
    • 10.19.5 Entropy
  • 10.20 Besco Medical Limited
    • 10.20.1 Company Overview
    • 10.20.2 Company Snapshot
    • 10.20.3 Financial Overview
    • 10.20.4 Product Listing
    • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Oxygen Therapy Equipment Market in Global (2022-2032)
  • Table 2: Oxygen Therapy Equipment Market in Global by Product Type (2022-2032)
  • Table 3: Oxygen Therapy Equipment Market in Global by Portability (2022-2032)
  • Table 4: Oxygen Therapy Equipment Market in Global by Application (2022-2032)
  • Table 5: Oxygen Therapy Equipment Market in Global by End-Users (2022-2032)
  • Table 6: Oxygen Therapy Equipment Market in Global by Geography (2022-2032)
  • Table 7: Oxygen Therapy Equipment Market in North America (2022-2032)
  • Table 8: Oxygen Therapy Equipment Market in the United States (2022-2032)
  • Table 9: Oxygen Therapy Equipment Market in Canada (2022-2032)
  • Table 10: Oxygen Therapy Equipment Market in Mexico (2022-2032)
  • Table 11: Oxygen Therapy Equipment Market in Europe (2022-2032)
  • Table 12: Oxygen Therapy Equipment Market in France (2022-2032)
  • Table 13: Oxygen Therapy Equipment Market in Germany (2022-2032)
  • Table 14: Oxygen Therapy Equipment Market in United Kingdom (2022-2032)
  • Table 15: Oxygen Therapy Equipment Market in Italy (2022-2032)
  • Table 16: Oxygen Therapy Equipment Market in Spain (2022-2032)
  • Table 17: Oxygen Therapy Equipment Market in the Rest of Europe (2022-2032)
  • Table 18: Oxygen Therapy Equipment Market in Asia-Pacific (2022-2032)
  • Table 19: Oxygen Therapy Equipment Market in China (2022-2032)
  • Table 20: Oxygen Therapy Equipment Market in Japan (2022-2032)
  • Table 21: Oxygen Therapy Equipment Market in India (2022-2032)
  • Table 22: Oxygen Therapy Equipment Market in Australia (2022-2032)
  • Table 23: Oxygen Therapy Equipment Market in South Korea (2022-2032)
  • Table 24: Oxygen Therapy Equipment Market in Rest of Asia-Pacific (2022-2032)
  • Table 25: Oxygen Therapy Equipment Market in the Rest of the World (2022-2032)
  • Table 26: Oxygen Therapy Equipment Market in the Middle East (2022-2032)
  • Table 27: Oxygen Therapy Equipment Market in Africa (2022-2032)
  • Table 28: Oxygen Therapy Equipment Market in South America (2022-2032)
  • Table 29: Competitive Landscape
  • Table 30: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Oxygen Therapy Equipment Market Drivers
  • Figure 2: Oxygen Therapy Equipment Market Restraints
  • Figure 3: Oxygen Therapy Equipment Market Opportunities
  • Figure 4: AI-Powered Innovations in the Oxygen Therapy Equipment Market
  • Figure 5: US Tariff Impact on Oxygen Therapy Equipment Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Oxygen Therapy Equipment Market in Global (2022-2032)
  • Figure 10: Oxygen Therapy Equipment Market in Global by Product Type (2022-2032)
  • Figure 11: Oxygen Therapy Equipment Market in Global by Portability (2022-2032)
  • Figure 12: Oxygen Therapy Equipment Market in Global by Application (2022-2032)
  • Figure 13: Oxygen Therapy Equipment Market in Global by End-Users (2022-2032)
  • Figure 14: Oxygen Therapy Equipment Market in Global by Geography (2022-2032)
  • Figure 15: Oxygen Therapy Equipment Market in North America (2022-2032)
  • Figure 16: Oxygen Therapy Equipment Market in the United States (2022-2032)
  • Figure 17: Oxygen Therapy Equipment Market in Canada (2022-2032)
  • Figure 18: Oxygen Therapy Equipment Market in Mexico (2022-2032)
  • Figure 19: Oxygen Therapy Equipment Market in Europe (2022-2032)
  • Figure 20: Oxygen Therapy Equipment Market in France (2022-2032)
  • Figure 21: Oxygen Therapy Equipment Market in Germany (2022-2032)
  • Figure 22: Oxygen Therapy Equipment Market in United Kingdom (2022-2032)
  • Figure 23: Oxygen Therapy Equipment Market in Italy (2022-2032)
  • Figure 24: Oxygen Therapy Equipment Market in Spain (2022-2032)
  • Figure 25: Oxygen Therapy Equipment Market in the Rest of Europe (2022-2032)
  • Figure 26: Oxygen Therapy Equipment Market in Asia-Pacific (2022-2032)
  • Figure 27: Oxygen Therapy Equipment Market in China (2022-2032)
  • Figure 28: Oxygen Therapy Equipment Market in Japan (2022-2032)
  • Figure 29: Oxygen Therapy Equipment Market in India (2022-2032)
  • Figure 30: Oxygen Therapy Equipment Market in Australia (2022-2032)
  • Figure 31: Oxygen Therapy Equipment Market in South Korea (2022-2032)
  • Figure 32: Oxygen Therapy Equipment Market in Rest of Asia-Pacific (2022-2032)
  • Figure 33: Oxygen Therapy Equipment Market in the Rest of the World (2022-2032)
  • Figure 34: Oxygen Therapy Equipment Market in the Middle East (2022-2032)
  • Figure 35: Oxygen Therapy Equipment Market in Africa (2022-2032)
  • Figure 36: Oxygen Therapy Equipment Market in South America (2022-2032)
  • Figure 37: Competitive Landscape
  • Figure 38: Startup Funding & Investment Trends